|
|||||||
|
Although recent advancements in rheumatoid arthritis (RA) therapies have led to a increased number of available treatments, quite a few of those therapies have side effects that result in some users discontinuing treatment or seeking complementary and alternative medicines. A recently published study shows that the Chinese herb Tripterygium wilfordii Hook F (TwHF), also [...]
T-Cell (Orange) A new one time treatment is being tested by scientists in Great Britain which could potentially “switch off” rheumatoid arthritis. The researchers are theorizing that the drug will turn off the immune system response that is the cause of the debilitating disease. This may put the RA patient into remission for years, [...]
Macrophage In a properly functioning immune system, the immune cells are supposed to die after attacking an invading bacteria or virus. This process of cell death is called apoptosis. “In apoptosis, a cell quietly dies off and gets removed from the system. That’s the way our body has of renewing itself all the time. [...] Scientists have found that in countries where parasitic infections are common the incidence of autoimmune diseases is relatively small. One hypothesis is that a chemical secreted by parasitic worms may have anti-inflammatory properties. If true, it may lead to a potential treatment for rheumatoid arthritis. [...] A novel new drug, based on the commonly used prednisone, has been recommended for European regulatory approval for treatment of morning stiffness resulting from rheumatoid arthritis. [...] A review of the five most recent anakinra trials has shown that the drug reduced stiffness and pain in patients, as well as improved joint function, when compared to placebo. [...] Researchers at the Hanson Institute in Adelaide and the St. Vincent’s Institute in Melbourne believe they have made great progress on developing a new treatment which will ‘stop’ leukemia and inflammatory diseases, such as rheumatoid arthritis and asthma. [...] |
  
|
||||||
|
Copyright © 2012 Current Arthritis News and Research - All Rights Reserved
|
|||||||
